Ocular Pain Global Clinical Trials Review, H2, 2014

Page 1

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

Ocular Pain Global Clinical Trials Review, H2, 2014 Published on July 2014

Report Summary Ocular Pain Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, 'Ocular Pain Global Clinical Trials Review, H2, 2014" provides data on the Ocular Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ocular Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ocular Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Content Table of Contents Table of Contents 2

Introduction 5 Ocular Pain 5 Report Guidance 5 Clinical Trials by Region 6

Ocular Pain Global Clinical Trials Review, H2, 2014 (From Issuu)

Page 1/6


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Clinical Trials and Average Enrollment by Country 7 Top Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Clinical Trials by G7 Countries: Proportion of Ocular Pain to Central Nervous System Clinical Trials 13 Clinical Trials in G7 Countries by Trial Status 14 Clinical Trials by E7 Countries: Proportion of Ocular Pain to Central Nervous System Clinical Trials 15 Clinical Trials by Phase 16 In Progress Trials by Phase 17 Clinical Trials by Trial Status 18 Clinical Trials by End Point Status 19 Subjects Recruited Over a Period of Time 20 Clinical Trials by Sponsor Type 21 Prominent Sponsors 22 Top Companies Participating in Ocular Pain Therapeutics Clinical Trials 23 Prominent Drugs 24 Clinical Trial Profiles 25 Clinical Trial Overview of Top Companies 25 Valeant Pharmaceuticals International, Inc. 25 Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 25 Reata Pharmaceuticals, Inc. 26 Clinical Trial Overview of Reata Pharmaceuticals, Inc. 26 Zeltia, S.A. 27 Clinical Trial Overview of Zeltia, S.A. 27 Ocular Therapeutix, Inc. 28 Clinical Trial Overview of Ocular Therapeutix, Inc. 28 Novartis AG 29 Clinical Trial Overview of Novartis AG 29 Kala Pharmaceuticals, Inc. 30 Clinical Trial Overview of Kala Pharmaceuticals, Inc. 30 InSite Vision Incorporated 31 Clinical Trial Overview of InSite Vision Incorporated 31 Clinical Trial Overview of Top Institutes / Government 32 Virdi Eye Clinic 32 Clinical Trial Overview of Virdi Eye Clinic 32 Isfahan University of Medical Sciences 33 Clinical Trial Overview of Isfahan University of Medical Sciences 33 Qazvin University Of Medical Sciences 34 Clinical Trial Overview of Qazvin University Of Medical Sciences 34 Mahidol University 35 Clinical Trial Overview of Mahidol University 35 Five Key Clinical Profiles 36 Appendix 65 Abbreviations 65 Definitions 65 Research Methodology 66 Secondary Research 66

Ocular Pain Global Clinical Trials Review, H2, 2014 (From Issuu)

Page 2/6


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! About GlobalData 67 Contact Us 67 Disclaimer 67 Source 67 List of Tables

Ocular Pain Therapeutics, Global, Clinical Trials by Region, 2014* 6 Ocular Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7 Ocular Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8 Ocular Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9 Ocular Pain Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10 Ocular Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* 11 Ocular Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12 Proportion of Ocular Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13 Ocular Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14 Proportion of Ocular Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15 Ocular Pain Therapeutics, Global, Clinical Trials by Phase, 2014* 16 Ocular Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17 Ocular Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18 Ocular Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19 Ocular Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20 Ocular Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21 Ocular Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22 Ocular Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23 Ocular Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2014* 25 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Reata Pharmaceuticals, Inc., 2014* 26 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeltia, S.A., 2014* 27 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocular Therapeutix, Inc., 2014* 28 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 29 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Kala Pharmaceuticals, Inc., 2014* 30 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by InSite Vision Incorporated, 2014* 31 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Virdi Eye Clinic, 2014* 32 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2014* 33 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Qazvin University Of Medical Sciences, 2014* 34 Ocular Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2014* 35 List of Figures

Ocular Pain Therapeutics, Global, Clinical Trials by Region (%), 2014* 6 Ocular Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7 Ocular Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8 Ocular Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9 Proportion of Ocular Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13 Ocular Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14

Ocular Pain Global Clinical Trials Review, H2, 2014 (From Issuu)

Page 3/6


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Proportion of Ocular Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15 Ocular Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16 Ocular Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17 Ocular Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18 Ocular Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19 Ocular Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20 Ocular Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21 Ocular Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22 Ocular Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23 Ocular Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24 GlobalData Methodology 66

Ocular Pain Global Clinical Trials Review, H2, 2014 (From Issuu)

Page 4/6


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. Ocular Pain Global Clinical Trials Review, H2, 2014

Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 500.00

Quantity: _____

Site License--USD 5 000.00

Quantity: _____

Corporate License--USD 7 500.00

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

Ocular Pain Global Clinical Trials Review, H2, 2014 (From Issuu)

Page 5/6


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93

Ocular Pain Global Clinical Trials Review, H2, 2014 (From Issuu)

Page 6/6


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.